Fermentation revolution?

Trash becomes treasure as bio-waste yields valuable acetone and isopropanol

07-Feb-2024 - In a major stride towards sustainable industrial fermentation, a team of researchers at Delft University of Technology (TU Delft) in The Netherlands, has unveiled pioneering advancements in the purification of isopropanol and acetone from the fermentation of waste gases. The study, published in ...

Green chemistry: BAM investigates pharmaceutical production without solvents and CO₂ emissions

Pharmaceutical production with mechanochemistry

28-Nov-2022 - The Bundesanstalt für Materialforschung und -prüfung (BAM) is developing a more sustainable process to produce active pharmaceutical ingredients in a major EU project: The pilot project is intended to demonstrate the advantages of mechanochemistry for more environmentally friendly and CO2-neutral ...

Merck Opens €59 Million CDMO Facility to Address Demand for Critical Cancer Therapies

Expansion doubles production of the most highly potent active pharmaceutical ingredients (HPAPIs)

27-Jun-2022 - Merck announced that its Life Science business sector has doubled its high-potent active pharmaceutical ingredients (HPAPI) production capacity with the expansion of its facility in Verona, near Madison, Wisconsin, USA. This new €59 million, 70,000 square foot facility, officially opened, brings ...

METiS Joins the Roche Accelerator

Start-up combines cutting-edge AI data-driven algorithms, mechanism-driven quantum mechanics and molecular dynamics simulations

23-May-2022 - METiS announced officially joining the Roche Accelerator with the goal to tap into Roche’s global scientific expertise, laboratory facilities and foster collaboration discussions on formulation development and optimization with Roche Innovation Center Shanghai. "We are excited to become a member ...

On our way to the bio-economy: High-performance biocatalyst discovered

Future applications primarily in the production of active pharmaceutical ingredients, but also in the synthesis of fine chemicals expected

22-May-2020 - In the bioeconomy, biotechnological processes are replacing processes that rely on fossil resources. Microorganisms and enzymes are being used in targeted fashion as biocatalysts for industrial production. Researchers at the University of Bayreuth have now discovered an enzyme that offers great ...

Catalysts combination opens doors to making useful compounds

17-Aug-2018 - Researchers have developed a new method that aids in the process of making valuable compounds by using a unique combination of catalysts. Huimin Zhao, Professor of Chemical and Biomolecular Engineering and leader of the Biosystems Design research theme at the Carl R. Woese Institute for Genomic ...

Bachem to expand in asian markets

Subsidiary in Tokyo founded

23-Jul-2018 - Bachem announces the establishment of Bachem Japan K.K., a subsidiary in Tokyo, Japan. This new local presence in Asia will strengthen project and customer support and drive further business growth in the Asian market."This is an exciting step for Bachem", comments Dr. Anne-Kathrin Stoller, Chief ...

Merck Invests in its Biotech Manufacturing Site in Bari

New production line for the aseptic filling of biotech medicines under isolator

04-Oct-2017 - Merck will invest €35 million in a new production line for the aseptic filling of biotech medicines under isolator at its manufacturing site of Bari, Italy. The announcement was made as part of an event celebrating the 25th anniversary of the site and its leading role on the science and ...

Evonik is investing in NUMAFERM

Start-up makes the production of peptides more efficient

21-Sep-2017 - Through its Venture Capital unit, Evonik has invested in the start-up NUMAFERM and now holds a minority share in the spin-off of Heinrich Heine University Düsseldorf. The investment was made as part of a seed financing round and also includes investments by High-Tech Gründerfonds, the Business ...

Lonza Acquires Micro-Macinazione

Swiss company expert in the field of microniziation

07-Aug-2017 - Lonza has acquired Micro-Macinazione, providing micronization of active ingredients for the pharmaceutical and fine chemical industries. Micro-Macinazione, which had sales of ~ CHF 20 million in 2016, has 120 employees and is based in Monteggio, Switzerland. Micro-Macinazione was purchased from ...